|
|
|
Volumn 42, Issue 2, 2004, Pages 132-137
|
|
Clinical evaluation of tulobuterol patch in patients with mild or moderate persistent bronchial asthma-effects of long-term treatment on airway inflammation and hypersensitivity
a
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
ANDROSTANE DERIVATIVE;
BECLOMETASONE;
BETA ADRENERGIC RECEPTOR STIMULATING AGENT;
DRUG DERIVATIVE;
FLUTICASONE;
TERBUTALINE;
TULOBUTEROL;
AGED;
ARTICLE;
ASTHMA;
BRONCHUS HYPERREACTIVITY;
CLINICAL TRIAL;
DELAYED RELEASE FORMULATION;
DRUG COMBINATION;
FEMALE;
HOSPITALIZATION;
HUMAN;
INFLAMMATION;
INHALATIONAL DRUG ADMINISTRATION;
INTRADERMAL DRUG ADMINISTRATION;
MALE;
MIDDLE AGED;
PATHOPHYSIOLOGY;
PEAK EXPIRATORY FLOW;
QUALITY OF LIFE;
TIME;
TREATMENT OUTCOME;
ADMINISTRATION, CUTANEOUS;
ADMINISTRATION, INHALATION;
ADRENERGIC BETA-AGONISTS;
AGED;
ANDROSTADIENES;
ASTHMA;
BECLOMETHASONE;
BRONCHIAL HYPERREACTIVITY;
DELAYED-ACTION PREPARATIONS;
DRUG THERAPY, COMBINATION;
FEMALE;
HUMANS;
INFLAMMATION;
MALE;
MIDDLE AGED;
PEAK EXPIRATORY FLOW RATE;
QUALITY OF LIFE;
SEVERITY OF ILLNESS INDEX;
TERBUTALINE;
TIME FACTORS;
TREATMENT OUTCOME;
|
|
EID: 2142703684
PISSN: 13433490
EISSN: None
Source Type: Journal
DOI: None Document Type: Article |
|
Times cited : (4)
|
|
References (0)
|
